Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1131
S.1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 16, 2017
- Latest Major Action May 16, 2017
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - May 16, 2017
Bill Summary
Fair Accountability and Innovative Research Drug Pricing Act of 2017 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products with a wholesale cost of $100 or more per month to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the cost of a drug over a 12-month period or a 25% or more increase over a 36-month period....
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 16, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| May 16, 2017 |
Introduced in the Senate by Tammy Baldwin (D-Wis.) |